<SEC-DOCUMENT>0000882104-21-000025-index.html : 20210202 <SEC-HEADER>0000882104-21-000025.hdr.sgml : 20210202 <ACCEPTANCE-DATETIME>20210202161833 ACCESSION NUMBER: 0000882104-21-000025 CONFORMED SUBMISSION TYPE: POS AM PUBLIC DOCUMENT COUNT: 1 REFERENCES 429: 333-145262 FILED AS OF DATE: 20210202 DATE AS OF CHANGE: 20210202 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PDL BIOPHARMA, INC. CENTRAL INDEX KEY: 0000882104 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943023969 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: POS AM SEC ACT: 1933 Act SEC FILE NUMBER: 333-145262 FILM NUMBER: 21581688 BUSINESS ADDRESS: STREET 1: 59 DAMONTE RANCH PARKWAY STREET 2: SUITE B-375 CITY: RENO STATE: NV ZIP: 89521 BUSINESS PHONE: 775-832-8500 MAIL ADDRESS: STREET 1: 59 DAMONTE RANCH PARKWAY STREET 2: SUITE B-375 CITY: RENO STATE: NV ZIP: 89521 FORMER COMPANY: FORMER CONFORMED NAME: PROTEIN DESIGN LABS INC/DE DATE OF NAME CHANGE: 19930328 </SEC-HEADER> <DOCUMENT> <TYPE>POS AM <SEQUENCE>1 <FILENAME>a20210202s-8doc.htm <DESCRIPTION>POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 <TEXT> Document 1 - file: a20210202s-8doc.htm
</DOCUMENT> </SEC-DOCUMENT>